Intelsius launches Plantol PCM
It will be beneficial for the transport of whole blood products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Almost all major manufacturers of pharma products in India have acknowledged and responded to the…
Javin Bhinde, Managing and Chief Executive Officer, SynCore Consulting shares details of the PatientSafe India conference this…
A Clash of IPR Cultures
India’s recently released national IPR policy has spurred fresh sparring between various lobbies. As international pressure to…
IPR in the Indo-US pharma trade relationship
India has retained her place on the Priority Watch List of the US TR's Super 301 report. With the Cabinet approving the National…
M&As ka Side Effects
Indian pharma companies have notched up some aggressive global buys recently but the sector's experience with cross border…
Going Green
Though the government is encouraging pharma companies to explore less accessed zones across India, it also expects companies to…
Are We Grappling Skewed Perceptions of GMP?
Indian Pharma Inc's waking up to the importance of GMP compliance and it has become a top priority in board room meetings but…
‘The companies who export must comply with the regulations of the importing country’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some…
Pharma quality assurance in 21st century: Sharper focus needed on education, training and…
Ajaz S Hussain, Founder CEO, Insight Advice & Solutions, and President, The National Institute for Pharmaceutical Technology…
Building quality excellence in pharma industry
With the pharma industry expanding scale and complexity, quality has emerged as a major focus area. Is quality merely a risk to be…
Pharma quality and compliance: Has the ‘elephant in the boardroom’ been recognised?
SM Mudda, Chairman, Regulatory Affairs Committee, IDMA, Mumbai examines where India’s pharma industry stands in terms of current…
Indian pharma: Bad at GMP compliance or victim of unwarranted regulatory expectations?
Viranchi Shah, Vice Chairman, Indian Drug Manufacturers’ Association (IDMA), opines that India's role in global healthcare cannot…
Tackling GMP non-compliance: A top priority!
Suresh Pareek,Managing Director, Ideal Cures emphasises the importance of eliminating GMP non-compliance and points out that its…
Battling non-conformance to quality
Michael Payne, Principal Technical Consultant, Process Solutions, Merck elaborates on the need to evaluate the quality systems in…
Setting up greenfield projects: Doing it the right way!
Vilas Dholye, Independent Pharma Consultant outlines the measures that need to be implemented at the planning/ construction stage…
Information security of computerised systems for global compliance
Arjun Guha Thakurta, Director – Operations, Life Science Consulting (a Convalgroup Company), emphasises on deploying an effective…
Transforming businesses from good to great!
Dr Shruti U Bhat, Director Strategic Innovations, Continuous improvement and Training; Shifting Paradigms BC Canada elaborates on…
Drug metabolism – Metabolite identification using advance LC-MS/MS system
Dr Vijayabhasker V, Principal Scientist, GVK Bio, Hyderabad, Dr Pratima Srivastava, Associate Director, Biology, GVK Bio,…
Still leading the race?
Maharashtra, a traditional hub of the Indian pharma industry, could face an uphill task to retain its decades-old dominance in…
Maharashtra, the pharma capital
Suresh G Kare, Chairman, Indoco Remedies, elaborates why Maharashtra has been a preferred destination for the pharma sector